Read on Twitter
Important notes from Idaho COVID-19 from today& #39;s @IDHW briefing:
- 2% of Idahoans skipped their 2nd dose of vaccine (that& #39;s very low, which is good)
- Vaccines now available regardless of whether you live or work in Idaho
- We& #39;ve had 2 weeks of declining vaccine uptake (not good)
- 2% of Idahoans skipped their 2nd dose of vaccine (that& #39;s very low, which is good)
- Vaccines now available regardless of whether you live or work in Idaho
- We& #39;ve had 2 weeks of declining vaccine uptake (not good)
Dr. Christine Hahn says @IDHW is urging health care providers to add their vaccine info to Vaccine Finder, and Idahoans can use it to find vaccines near them. https://vaccinefinder.org/search/ ">https://vaccinefinder.org/search/&q...
Now at 215 variant cases, in 17 counties. Of those, 75% are B.1.1.7 (UK) and 20% are B.1.427/429 (CA). Two infections with B.1.351 (S. Africa). Three people identified with B.1.526 (New York). And *possibly* a P.1 (Brazil) variant, which would be the first such case in Idaho.
They& #39;re also watching for the B.1.617 variant, which was first detected in India last winter. This variant has been detected in the U.S., hasn& #39;t been detected yet in Idaho.
Now at 190 Idahoans infected after being fully vaccinated. Average age 58 years old, ages range from 18 to over 100 years old. Of these, 4 people hospitalized, and 1 person has died in the last week. "Just a reminder of how bad COVID-19 infection can be."
These "breakthrough" cases of post-vax infection are mostly women. Why? Don& #39;t know. Some possibilities:
- Women have been getting vaccinated more than men, so they make up more of the "n"
- Women may be getting tested more
- Something related to physiology
- Women have been getting vaccinated more than men, so they make up more of the "n"
- Women may be getting tested more
- Something related to physiology
Side note from me: Deaths from COVID-19 have consistently leaned male. So, men in Idaho are going to be at even higher risk of death than women are, if this vaccine trend continues.
